Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
14
Number of overlapping holdings
11.9%
% of XBI's 119 holdings also in IBRN
33.3%
% of IBRN's 60 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 2.6% | 4.2% | 2.6% |
|
BIOGEN IDEC INC | 2.5% | 3.9% | 2.5% |
|
SAREPTA THERAPEUTICS INC | 1.6% | 2.9% | 1.6% |
 |
ALKERMES PLC | 1.1% | 4.1% | 1.1% |
|
SCHOLAR ROCK HOLDING CORP. | 0.8% | 3.9% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to IBRN
|
ALNYLAM PHARMACEUTICALS INC | 2.8% |
|
INSMED INC | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.5% |
|
NATERA INC | 2.5% |
|
VERTEX PHARMACEUTICALS INC | 2.5% |
|
AMGEN INC | 2.4% |
|
GILEAD SCIENCES INC | 2.4% |
|
ABBVIE INC | 2.4% |
|
EXACT SCIENCES CORP | 2.3% |
|
REGENERON PHARMACEUTICALS | 2.3% |
XBI Underweight Relative to IBRN
|
INTRA-CELLULAR THERAPIES INC | -4.2% |
 |
ARGENX SE ADR | -4.2% |
|
CATALYST PHARMACEUTICAL PART | -4.1% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.9% |
|
SUPERNUS PHARMACEUTICALS INC | -3.7% |
|
PTC THERAPEUTICS INC | -3.6% |
|
EDGEWISE THERAPEUTICS, INC. | -3.3% |
|
ACADIA PHARMACEUTICALS INC | -3.3% |
|
DENALI THERAPEUTICS INC. | -3.3% |
|
INTEGRA LIFESCIENCES HOLDING | -3.1% |